Veer Bala Gupta

Research interests

Publications

• The global epidemiology and health burden of the autism spectrum: findings from the Global Burden of Disease Study 2021

  The Lancet Psychiatry · 2024 · 10.1016/s2215-0366(24)00363-8

• Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021

  The Lancet Rheumatology · 2023 · https://doi.org/10.1016/s2665-9913(23)00163-7

• Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

  The Lancet Rheumatology · 2023 · https://doi.org/10.1016/s2665-9913(23)00211-4

• Retinal pathological features and proteome signatures of Alzheimer’s disease

  Acta Neuropathologica · 2023 · 10.1007/s00401-023-02548-2

• The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis

  The Lancet Public Health · 2022 · 10.1016/s2468-2667(22)00225-0

• The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019

  The Lancet Healthy Longevity · 2022 · 10.1016/s2666-7568(22)00213-6

• Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

  The Lancet Public Health · 2022 · https://doi.org/10.1016/s2468-2667(21)00249-8

• Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019

  The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00516-x

• Retinal changes in Alzheimer's disease— integrated prospects of imaging, functional and molecular advances

  Progress in Retinal and Eye Research · 2020 · 10.1016/j.preteyeres.2020.100899

• Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review

  Molecular Neurobiology · 2020 · 10.1007/s12035-020-02054-6

• Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis

  Cellular and Molecular Life Sciences · 2019 · 10.1007/s00018-019-03040-5

• Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

  Journal of Alzheimer s Disease · 2018 · 10.3233/jad-171145

• Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes

  Scientific Reports · 2017 · 10.1038/s41598-017-12858-7

• Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults

  British Journal Of Nutrition · 2016 · 10.1017/s0007114516001203

• Blood‐based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic

  Alzheimer s & Dementia · 2016 · 10.1016/j.jalz.2016.09.014

• Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease research

  Alzheimer s & Dementia · 2014 · 10.1016/j.jalz.2014.08.099

• BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma

  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2014 · 10.1016/j.bbadis.2014.05.026

• BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma

  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2014 · 10.1016/j.bbadis.2014.05.026

• TrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders

  International Journal of Molecular Sciences · 2013 · 10.3390/ijms140510122

• Intense physical activity is associated with cognitive performance in the elderly

  Translational Psychiatry · 2012 · 10.1038/tp.2012.118

• Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease

  Molecular Psychiatry · 2012 · 10.1038/mp.2012.147

• Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing

  Molecular Psychiatry · 2012 · 10.1038/mp.2012.107

• Plasma apolipoprotein E and Alzheimer disease risk

  Neurology · 2011 · 10.1212/wnl.0b013e318211c352

• Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging

  Journal of Alzheimer s Disease · 2010 · 10.3233/jad-2010-090249

• Aluminium in Alzheimer?s disease: are we still at a crossroad?

  Cellular and Molecular Life Sciences · 2005 · 10.1007/s00018-004-4317-3

Current projects

No projects listed.